N-Ethylhexedrone was patented by the German pharmaceutical firm Boehringer Ingelheim in 1964 as a potential anorexigenic agent. The patent describes its synthesis together with other derivatives of aminoketone.[1]The toxicity and very long-time period health and fitness consequences of leisure N-ethylhexedrone use do not appear to have been researc